Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does Treatment of Androgen Excess Using Spironolactone Improve Ovulatory Rates in Girls With Androgen Excess?

NCT04075149 is registered in ClinicalTrials.gov with University of Virginia as lead sponsor.

NCT NCT04075149
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04075149 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does Treatment of Androgen Excess Using Spironolactone Improve Ovulatory Rates in Girls With Androgen Excess?
Lead sponsor
University of Virginia
Phase
Phase 1
Overall status
Unknown status
Start date
December 18, 2019
Completion date
September 1, 2024
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovulation disorder, polycystic ovary syndrome, puberty disorders